Deal Ends TodayยทSave 35% annual plan
IL-4/IL-13 receptor antagonist / specialty biologicReviewed for 2026 plan year

Does Cigna Cover Dupixent?

The verdict

Covered on most plans

Cigna covers Dupixent on the specialty tier (Tier 4 or 5) with prior authorization and indication-specific step therapy, managed through Express Scripts (PBM) and dispensed through Accredo specialty pharmacy. Commercial coinsurance is typically 20-50% โ€” wider than many insurers โ€” though the Dupixent MyWay copay card can reduce this to as low as $0 for eligible commercially insured patients. Medicare Part D coinsurance is approximately 31% after the deductible, capped at $2,100 for 2026. Dupixent can also flip to the medical benefit when administered in a clinical setting.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary โ€” always confirm with Cigna using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Cigna drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only โ€” not insurance advice

Key facts

  • Cigna uses Express Scripts as its pharmacy benefit manager (PBM) and Accredo as its specialty pharmacy for Dupixent โ€” patients must use Accredo for home dispensing to receive in-network cost-share.

    Cigna Healthcare โ€” specialty pharmacy and Express Scripts information

  • Commercial coinsurance for Dupixent at Cigna can range from approximately 20-50% depending on employer plan design โ€” the Dupixent MyWay copay card can reduce eligible commercially insured patients' cost to as little as $0.

    Sanofi/Regeneron โ€” Dupixent MyWay patient access program

  • The 2026 Medicare Part D out-of-pocket cap is $2,100; specialty biologic patients reaching this cap pay $0 for covered drugs for the rest of the calendar year.

    CMS.gov โ€” Medicare Part D benefit parameters 2026

Plan types

Medicare vs. commercial coverage

Whether Cigna covers Dupixent depends heavily on which kind of plan you hold. They follow completely different rules โ€” here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Medicare Part D plans (Cigna Healthcare Medicare): Dupixent is on the specialty tier with PA and step therapy via Express Scripts. Members pay approximately 31% coinsurance after the deductible, capped at $2,100 for 2026 โ€” the plan pays 100% of cost above that cap for the rest of the year. Per Sanofi/Regeneron, about 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under post-IRA catastrophic protections. The Dupixent MyWay copay card cannot be used by Medicare beneficiaries. When Dupixent is administered in a clinic, it may shift to Medicare Part B rather than Part D.

Commercial / Employer

Group & marketplace plans

Covered

Commercial/Employer plans: Dupixent is covered on the specialty tier (Tier 4 or 5) via Express Scripts with dispensing through Accredo specialty pharmacy. Commercial coinsurance is approximately 20-50% โ€” a composite range that reflects the wide variation across Cigna plan designs; the exact percentage depends on the employer plan. This is a notably wide band compared to many insurers and the part patients most often find surprising. The Dupixent MyWay copay card (Sanofi/Regeneron) can reduce cost to as little as $0 for eligible commercially insured patients. ACA/Individual marketplace Cigna plans cover Dupixent on the specialty tier with PA where offered. Medicaid: Cigna-managed Medicaid covers Dupixent per state PDL with PA and step therapy; nominal cost-share. Medical vs. pharmacy benefit: primarily pharmacy-benefit self-injected via Accredo; can flip to Part B/medical benefit when clinic-administered.

Prior authorization

The 5 boxes you must tick to get approved

Commercial plans that will consider Dupixent require prior authorization. Check off what applies to you to see how close you are โ€” this is a guide, not a guarantee of approval.

Requirements you meet0 / 5

Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Dupixent actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Approximately $3,993 per carton of 2 pre-filled pens (list price, Jan 2025 estimate); average retail approximately $5,350-$5,377 per month (estimate). All cash figures are estimates โ€” verify current pricing before use.

List price with no coverage โ€” before any manufacturer savings card.

PA approved

With coverage

Commercial specialty tier: approximately 20-50% coinsurance (composite range; varies by Cigna employer plan design). Medicare Part D: approximately 31% coinsurance after the deductible, capped at $2,100 for 2026. Medicaid: nominal cost-share. This 20-50% commercial band is wider than most insurers โ€” confirm your exact coinsurance on your Cigna Summary of Benefits.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Dupixent MyWay copay program (Sanofi/Regeneron): as little as $0 per month for eligible commercially insured patients. Not available to Medicare, Medicaid, or other government-plan enrollees. Enroll at dupixent.com/myway or call 1-844-DUPIXENT.

Reduced copay through the assistance program, where eligible.

The 20-50% commercial coinsurance range is a composite across Cigna plan designs and is not a plan-specific line item. Confirm your actual coinsurance on your plan's Summary of Benefits or by calling the member services number on your Cigna insurance card or using the Express Scripts cost tool.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Search Dupixent on myCigna.com or the Express Scripts drug-lookup tool

    Log into myCigna.com and use the drug-cost estimator or formulary search tool. You can also go directly to Express Scripts (express-scripts.com) with your member ID. Search for both 'Dupixent' and 'dupilumab.' Note the tier, PA or step-therapy requirements, and that Accredo is the required specialty pharmacy.

  2. 2

    Have your specialist submit a Prior Authorization through Express Scripts

    Your allergist, dermatologist, pulmonologist, or gastroenterologist submits the PA to Express Scripts. Provide clinical documentation: diagnosis, prior treatment history showing step-therapy completion, current disease severity scores, and supporting lab values (e.g., eosinophil count for asthma). The PA typically takes 24-72 hours for a standard review.

  3. 3

    Enroll in Dupixent MyWay if you are commercially insured

    Because commercial coinsurance at Cigna can run 20-50%, the Dupixent MyWay copay card is especially valuable for Cigna commercial members. Enroll at dupixent.com/myway after Accredo confirms dispensing. For Medicare beneficiaries, the $2,100 (2026) Part D cap limits annual exposure; ask about Medicare Extra Help for additional assistance.

If it's denied

Options if Cigna won't cover Dupixent

A denial isn't the end of the road. These are the paths people commonly explore next โ€” discuss any of them with your prescriber.

Topical corticosteroids and calcineurin inhibitors

For atopic dermatitis: required step-therapy agents before Dupixent under Express Scripts criteria. Documented failure or contraindication to mid-to-high potency topical steroids and tacrolimus/pimecrolimus is typically required for PA approval.

Xolair (omalizumab), Nucala (mepolizumab), Tezspire (tezepelumab)

For asthma: preferred biologics that Express Scripts may require as step therapy before Dupixent, depending on phenotype. Your asthma management must be documented as inadequately controlled on standard ICS/LABA therapy.

JAK inhibitors (Rinvoq, Cibinqo)

Some Cigna commercial plans include a JAK inhibitor trial requirement for moderate-to-severe atopic dermatitis before approving Dupixent. Verify Cigna's specific atopic dermatitis PA criteria through Express Scripts.

These options are listed for information only โ€” your own clinician decides what is appropriate for you.

โ“Frequently Asked Questions

Yes, Cigna covers Dupixent on the specialty tier (Tier 4 or 5) with prior authorization and indication-specific step therapy, managed through Express Scripts and dispensed through Accredo specialty pharmacy. Coverage is broad across commercial, Medicare Part D, and Medicaid lines. The main surprises for Cigna members are the wide commercial coinsurance range (20-50%) and the Accredo dispensing requirement.

Cigna's commercial coinsurance for specialty-tier drugs can range from 20-50% depending on the specific employer plan design. This is a wider band than many insurers because Cigna offers numerous commercial plan structures, and each employer group negotiates its own benefit design. The Dupixent MyWay copay card (available to eligible commercially insured patients) can reduce your actual out-of-pocket cost to as little as $0, making the coinsurance percentage much less relevant for most commercial members.

Yes, Accredo is Cigna's designated specialty pharmacy under Express Scripts for Dupixent dispensing. Accredo ships directly to your home. Using an out-of-network specialty pharmacy will result in higher cost-share or claim denial under most Cigna plans. After your PA is approved by Express Scripts, Accredo coordinates the shipment and provides clinical pharmacist support.

On Cigna Medicare Part D, Dupixent coinsurance is approximately 31% after the deductible. However, the $2,100 (2026) Part D out-of-pocket cap limits total annual drug spending โ€” once you reach that, you pay nothing further for covered drugs for the rest of the year. About 79% of Medicare Part D Dupixent recipients pay $0-$100 per month per Sanofi/Regeneron. The Dupixent MyWay copay card cannot be used on Medicare.

Dupixent is primarily dispensed as a self-injected pharmacy-benefit drug through Accredo under Express Scripts. However, when a clinician administers Dupixent in an office or infusion-center setting, it can shift to the medical benefit โ€” billed under Part B for Medicare or under the medical cost-share for commercial plans. Most patients self-inject at home under the pharmacy benefit.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date โ€” always verify current benefits directly with Cigna before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.